Melphalan 140mg/m2 or 200mg/m2 for autologous...

Melphalan 140mg/m2 or 200mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.

Auner, Holger W, Iacobelli, Simona, Sbianchi, Giulia, Knol-Bout, Cora, Blaise, Didier, Russell, Nigel H, Apperley, Jane F, Pohlreich, David, Browne, Paul, Kobbe, Guido, Isaksson, Cecilia, Lenhoff, Sti
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2017.181339
Date:
December, 2017
File:
PDF, 849 KB
english, 2017
Conversion to is in progress
Conversion to is failed